Genprex (NASDAQ::GNPX) is a clinical-stage biopharmaceutical company focused on the development of novel gene therapies for patients with cancer and diabetes who have limited treatment options. The Company works with world-class research institutions to identify and advance emerging and disruptive therapies.Genprex’s oncology program utilizes a unique, proprietary, non-viral nanoparticle delivery system, called "Oncoprex", to deliver cancer fighting genes back into the human body. Oncoprex is first systemic gene therapy delivery platform used for cancer in humans. Genprex's lead product candidate, REQORSA™ (quaratusugene ozeplasmid), is being evaluated as a treatment for lung cancer (NSCLC and SCLC). The FDA has granted three Fast Track Designations and an Orphan Drug Designation for REQORSA for lung cancer patients in combination with approved therapies from AstraZeneca, Merck and Genentech. Genprex’s diabetes program utilizes a novel infusion process to deliver genes locally to the pancreas through a traditional ERCP via AAV delivery to convert alpha cells into beta-like cells via transdifferentiation. These beta-like cells are able to produce insulin and are distinct enough from beta cells to evade the typical immune response associated with T1D. Our preclinical programs have shown statistically significant results in the creation of new beta cell mass and insulin production and sustained glucose stabilization over durable periods in humanized mice, human islet cells, and non-human primates subjects. For more information, please visit www.genprex.com.

I worked closely with founding CEO, David Nance (former CEO of Introgen Therapeutics), to build a strategic business and financial plan to launch the company and seek early-stage investment.

Gurnade is a creative design agency and automotive tuner. The Company's bread-and-butter is the development of hyper-realistic conceptual designs and their subsequent conversion into high-quality products (what industry refers to as "render to reality"). Our quality craftsmanship has lead to collaboration and partnerships with some of the most reputable automotive brands in the world. Gurnade's work has been on display at the largest and most renown automotive shows in the world (e.g. the SEMA Show, the LA Auto Show, Tokyo Auto Salon, etc).

Confer Capital, Inc is a technology-focused advisory services boutique with a focus on transitioning ideas thru commercialization. We have specialized client advisors that have broad and focused advisory in industries including biopharma, medical devices, SaaS, oil & gas, and financial services. Our core competencies include: negotiating technology licensing and transfer, developing strategic financial and business model analysis, market analysis and GTM strategy, investment analysis and strategy, private and public market financing, investor relations, sales and product development strategies, and advanced growth strategies.

Innovate Texas Foundation connects Texas's wealth of intellectual capital with financial capital, human capital, entrepreneurs, universities, businesses, government, and technology communities to strengthen Texas as a global leader in the innovation economy and to create economic abundance for Texans.• Mission & strategy endorsed in July 2008 State of Texas' Competitiveness Councils (nominated by Gov Rick Perry) Report;• Spearheaded research of >3000 Texas stakeholders determining lack of access to innovation resources;• Raised over $2M funding from Department of Labor grants & private donors to launch organization;• Mentored & advised over 250 technology commercialization projects & start-up companies;• Completed over 20 professional and executive training seminars on the topics of technology transfer, development, and commercialization to approximately 1000 attendees from 2009 to 2011;• Collaborated with major Texas universities (UT, TAMU, TTU, TXST) to develop technology commercialization curriculum;• Responsible for annual financial reporting, financial analysis and modeling, finance, accounting, compliance, human resources, operations, marketing, and technology development for the entity;• Managed several independent teams of 5-10 domain experts on the development of internal technical programs and evaluation of outside/spin-off technology transfer and commercialization opportunities;• Evaluated market opportunities, developed strategic business plans, assembled technical and business development teams, and developed strategic and financial partnerships to launch entities/initiatives;• Identified roles, interviewed, and hired management and technical employees, independent contractors, technical specialists, and specialized professional services firms; and• Identified commercially viable military technologies, recruited technical team members, negotiated SRAs, and filed for DOD and DARPA grants to enhance technology readiness level and valuation.

• Active Manager of a portfolio of 120+ early-stage start-up companies for a $500M+ early-stage technology investment fund;• Researched emerging technologies, markets, and industries to support due diligence and investment screening;• Managed relationships and trained eight regional commercialization deal-flow centers (RCICs) on investment screening best practices;• Negotiated deals and determined value-driven contractual milestones to trigger funding tranches; • Maintained cap tables, developed financial models, and developed portfolio management processes and metrics to monitor investment risk and evaluate deal and fund performance; and• Recognized nationally as the "Most Active Early-Stage Technology Venture Fund in the United States." - June 2008

• Performed financial analysis on over $2B in proposals to the Industrial Revenue Bond Program (IRB);• Developed liquidity & default risk provisions and a tiered lending structure for the Texas Leverage Fund (TLF);• Developed and proposed a revised operations and investment strategy for the Product Development & Small Business Incubator Programs (PDSBI);• Performed analysis and developed financial models for over $50M in proposals to the Texas Enterprise Fund (TEF); and• Trained finance team members on the development and usage of financial models to conduct analysis.